Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer

Development of high-throughput monitoring technologies enables interrogation of cancer samples at various levels of cellular activity. Capitalizing on these developments, various public efforts such as The Cancer Genome Atlas (TCGA) generate disparate omic data for large patient cohorts. As demonstrated by recent studies, these heterogeneous data sources provide the opportunity to gain insights into the molecular changes that drive cancer pathogenesis and progression. However, these insights are limited by the vast search space and as a result low statistical power to make new discoveries. In this paper, we propose methods for integrating disparate omic data using molecular interaction networks, with a view to gaining mechanistic insights into the relationship between molecular changes at different levels of cellular activity. Namely, we hypothesize that genes that play a role in cancer development and progression may be implicated by neither frequent mutation nor differential expression, and that network-based integration of mutation and differential expression data can reveal these “silent players”. For this purpose, we utilize network-propagation algorithms to simulate the information flow in the cell at a sample-specific resolution. We then use the propagated mutation and expression signals to identify genes that are not necessarily mutated or differentially expressed genes, but have an essential role in tumor development and patient outcome. We test the proposed method on breast cancer and glioblastoma multiforme data obtained from TCGA. Our results show that the proposed method can identify important proteins that are not readily revealed by molecular data, providing insights beyond what can be gleaned by analyzing different types of molecular data in isolation.

[1]  Manolis Kellis,et al.  Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014, Nature Neuroscience.

[2]  Forest M. White,et al.  Phosphoproteomics: unraveling the signaling web. , 2008, Molecular cell.

[3]  V. Band,et al.  Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders , 2011, Oncotarget.

[4]  Ivan Dikic,et al.  Signalling through the grapevine , 2012, EMBO reports.

[5]  Roded Sharan,et al.  Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..

[6]  Luca Laurenti,et al.  NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL , 2012, Haematologica.

[7]  Rosemary H. Tambouret,et al.  HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant. , 2015, Gynecologic oncology.

[8]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[9]  Vishal N. Patel,et al.  Network Signatures of Survival in Glioblastoma Multiforme , 2013, PLoS Comput. Biol..

[10]  D S Kobyakov,et al.  [Non-small cell lung cancer: HER2 oncogene status]. , 2015, Arkhiv patologii.

[11]  I Screpanti,et al.  Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation , 2014, Leukemia.

[12]  Mehmet Koyutürk,et al.  An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal Cancer , 2010, PLoS Comput. Biol..

[13]  Zena Werb,et al.  GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland , 2006, Cell.

[14]  Mehmet Koyutürk,et al.  Vavien: An Algorithm for Prioritizing Candidate Disease Genes Based on Topological Similarity of Proteins in Interaction Networks , 2011, J. Comput. Biol..

[15]  Eric S. McLamore,et al.  Altered glucose metabolism in Harvey‐ras transformed MCF10A cells , 2015, Molecular carcinogenesis.

[16]  H. Akaike A new look at the statistical model identification , 1974 .

[17]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[18]  Baolin Wu,et al.  Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment , 2013, PLoS Comput. Biol..

[19]  Martin H. Schaefer,et al.  HIPPIE: Integrating Protein Interaction Networks with Experiment Based Quality Scores , 2012, PloS one.

[20]  Andrew M. Gross,et al.  Network-based stratification of tumor mutations , 2013, Nature Methods.

[21]  Naveid A Ali,et al.  Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway. , 2013, Cancer research.

[22]  C. Sander,et al.  Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.

[23]  Jung-A Choi,et al.  Ras Promotes Transforming Growth Factor-β (TGF-β)-induced Epithelial-Mesenchymal Transition via a Leukotriene B4 Receptor-2-linked Cascade in Mammary Epithelial Cells* , 2014, The Journal of Biological Chemistry.

[24]  Patrick Nitschke,et al.  A human immunodeficiency caused by mutations in the PIK3R1 gene. , 2015, The Journal of clinical investigation.

[25]  Roded Sharan,et al.  Network-based interpretation of genomic variation data. , 2013, Journal of molecular biology.

[26]  D. Bennett,et al.  Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.

[27]  Emil Alexov,et al.  Understanding molecular effects of naturally occurring genetic differences. , 2013, Journal of molecular biology.

[28]  Michael F. Ochs,et al.  Activation of the NOTCH pathway in head and neck cancer. , 2014, Cancer research.

[29]  Eli Upfal,et al.  Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.

[30]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[31]  Linyi Chen,et al.  Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity , 2012, Oncotarget.

[32]  Bernhard Schölkopf,et al.  Learning with Local and Global Consistency , 2003, NIPS.

[33]  Aleix Prat Aparicio Comprehensive molecular portraits of human breast tumours , 2012 .

[34]  Renata C. Geer,et al.  The NCBI BioSystems database , 2009, Nucleic Acids Res..

[35]  A. Ferrando,et al.  The role of NOTCH1 signaling in T-ALL. , 2009, Hematology. American Society of Hematology. Education Program.

[36]  Teresa M. Przytycka,et al.  Identifying Causal Genes and Dysregulated Pathways in Complex Diseases , 2011, PLoS Comput. Biol..

[37]  L. Kiemeney,et al.  Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation , 2011, European Journal of Human Genetics.

[38]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[39]  Michael I. Jordan,et al.  Advances in Neural Information Processing Systems 30 , 1995 .

[40]  S. Kajigaya,et al.  Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. , 2000, Biochemical and biophysical research communications.

[41]  A. Porcellini,et al.  The p85 Regulatory Subunit of PI3K Mediates cAMP-PKA and Insulin Biological Effects on MCF-7 Cell Growth and Motility , 2014, TheScientificWorldJournal.

[42]  Manolis Kellis,et al.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .